Received Sep 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | cd44A | IM / LA |
reports that yesterday an 8 year old patient received Bexsero.; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 8-year-old male patient who received Men B NVS (Bexsero) (batch number cd44A, expiry date 31-AUG-2028) for prophylaxis. On 11-SEP-2025, the patient received Bexsero (intramuscular, left arm). On 11-SEP-2025, an unknown time after receiving Bexsero, the patient experienced inappropriate age at vaccine administration (Verbatim: reports that yesterday an 8 year old patient received Bexsero.). The outcome of the inappropriate age at vaccine administration was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 12-SEP-2025 The reporter was a medical assistant from a children clinic. The reporter reported that on 11st September 2025 an 8 year old patient received Bexsero which led to inappropriate age at vaccine administration.